Panacea Life Sciences Holdings, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $-399.7K | $-405.7K | $6.0K | $55.0K |
| FY2015 | $-640.0K | $-640.0K | $0 | $5.0K |
| FY2016 | $-891.0K | $-889.7K | $-1.3K | $100.0K |
| FY2017 | $-1.2M | $-1.2M | — | $0 |
| FY2018 | $-465.8K | $-465.8K | $0 | $892.1K |
| FY2019 | $-5.7M | $-6.3M | $541.2K | $3.8M |
| FY2020 | $-7.6M | $-10.8M | $3.2M | $1.4M |
| FY2021 | $-3.9M | $-4.1M | $162.9K | — |
| FY2022 | $-2.4M | $-2.6M | $243.8K | — |
| FY2023 | $-1.5M | $-1.6M | $65.3K | — |